Pricing

Novan Inc (NOVNQ)

followers ·
Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Paula B. Stafford
Employees:
30
P.O. BOX 64, PITTSBORO, NC, 27312
919-485-8080
Stock Split History
DateRatio
2021-05-26 1:10
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris. SB208, a broad-spectrum anti-fungal gel for the. treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections. SB207, an anti-viral product candidate for. the treatment. of external genital warts; WH602, a nitric. oxide-containing intravaginal gel to treat
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available